Found: 39
Select item for more details and to access through your institution.
Long‐term results of Waldenström macroglobulinaemia treatment by bendamustine and rituximab: A study on behalf of the French Innovative Leukemia Organization (FILO).
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 6, p. 2233, doi. 10.1111/bjh.19409
- By:
- Publication type:
- Article
Venetoclax induces profound and sustained responses in patients with relapsed/refractory light‐chain amyloidosis.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 3, p. 674, doi. 10.1111/bjh.17380
- By:
- Publication type:
- Article
Characterisation of a new clinical presentation of chronic lymphocytic leukaemia: symptomatic bronchial involvement, a study from the FILO group.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 5, p. e126, doi. 10.1111/bjh.15966
- By:
- Publication type:
- Article
Bendamustine plus rituximab in newly‐diagnosed Waldenström macroglobulinaemia patients. A study on behalf of the French Innovative Leukaemia Organization (FILO).
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 1, p. 146, doi. 10.1111/bjh.15718
- By:
- Publication type:
- Article
A susceptibility locus for classical Hodgkin lymphoma at 8q24 near <italic>MYC</italic>/<italic>PVT1</italic> predicts patient outcome in two independent cohorts.
- Published in:
- 2018
- By:
- Publication type:
- Abstract
Transformed Waldenström macroglobulinaemia: clinical presentation and outcome. A multi-institutional retrospective study of 77 cases from the French Innovative Leukemia Organization ( FILO).
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 3, p. 439, doi. 10.1111/bjh.14881
- By:
- Publication type:
- Article
Management of central nervous system involvement in chronic lymphocytic leukaemia: a retrospective cohort of 30 patients.
- Published in:
- British Journal of Haematology, 2017, v. 176, n. 1, p. 37, doi. 10.1111/bjh.14387
- By:
- Publication type:
- Article
Atrial fibrillation in CLL patients treated with ibrutinib. An international retrospective study.
- Published in:
- British Journal of Haematology, 2016, v. 175, n. 3, p. 462, doi. 10.1111/bjh.14324
- By:
- Publication type:
- Article
A phase II, single-arm, multicentre study of coltuximab ravtansine ( SAR3419) and rituximab in patients with relapsed or refractory diffuse large B-cell lymphoma.
- Published in:
- British Journal of Haematology, 2016, v. 173, n. 5, p. 722, doi. 10.1111/bjh.13992
- By:
- Publication type:
- Article
Long-term follow-up and second malignancies in 487 patients with hairy cell leukaemia.
- Published in:
- British Journal of Haematology, 2014, v. 166, n. 3, p. 390, doi. 10.1111/bjh.12908
- By:
- Publication type:
- Article
Real-world outcomes following venetoclax therapy in patients with chronic lymphocytic leukemia or Richter syndrome: a FILO study of the French compassionate use cohort.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 4, p. 987, doi. 10.1007/s00277-021-04419-w
- By:
- Publication type:
- Article
Alveolar rhabdomyosarcoma mimicking Burkitt-like lymphoma.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
Ibrutinib Associated with Rituximab-Platinum Salt-Based Immunochemotherapy in B-Cell Lymphomas: Results of a Phase 1b-II Study of the LYSA Group.
- Published in:
- Cancers, 2022, v. 14, n. 7, p. 1761, doi. 10.3390/cancers14071761
- By:
- Publication type:
- Article
Genetic Characterization and Clinical Features of Helicobacter pylori Negative Gastric Mucosa-Associated Lymphoid Tissue Lymphoma.
- Published in:
- Cancers, 2021, v. 13, n. 12, p. 2993, doi. 10.3390/cancers13122993
- By:
- Publication type:
- Article
Long‐term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma: A pooled analysis of four randomized trials.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 18, p. 6565, doi. 10.1002/cam4.3298
- By:
- Publication type:
- Article
Clinical spectrum, evolution, and management of autoimmune cytopenias associated with angioimmunoblastic T‐cell lymphoma.
- Published in:
- European Journal of Haematology, 2019, v. 103, n. 1, p. 35, doi. 10.1111/ejh.13239
- By:
- Publication type:
- Article
PET/CT before autologous stem cell transplantation predicts outcome in refractory/relapsed follicular lymphoma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2015, v. 42, n. 2, p. 215, doi. 10.1007/s00259-014-2896-2
- By:
- Publication type:
- Article
Bone marrow involvement in diffuse large B-cell lymphoma: correlation between FDG-PET uptake and type of cellular infiltrate.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2009, v. 36, n. 5, p. 745, doi. 10.1007/s00259-008-1021-9
- By:
- Publication type:
- Article
Effectiveness and Safety of Subcutaneous Rituximab for Patients With Gastric MALT Lymphoma: A Case-Control Comparison With Intravenous Rituximab.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Long-Term Follow-Up of Acalabrutinib Monotherapy in Patients with Relapsed/Refractory Mantle Cell Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S316, doi. 10.1016/j.clml.2019.07.291
- By:
- Publication type:
- Article
Hairy Cell Leukemia: Results of the French Retrospective Cohort After 10 Years of Follow Up.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S313, doi. 10.1016/j.clml.2019.07.285
- By:
- Publication type:
- Article
Sinusoidal Obstruction Syndrome: Warning About Autologous Stem Cell Transplantation Preceded by Regimens Containing Oxaliplatin.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S264, doi. 10.1016/j.clml.2019.07.185
- By:
- Publication type:
- Article
Improvement of Early <sup>18</sup>F-FDG PET Interpretation in Diffuse Large B-Cell Lymphoma: Importance of the Reference Background.
- Published in:
- Journal of Nuclear Medicine, 2010, v. 51, n. 12, p. 1857, doi. 10.2967/jnumed.110.080556
- By:
- Publication type:
- Article
Prognostic Value of Interim <sup>18</sup>F-FDG PET in Patients with Diffuse Large B-Cell Lymphoma: SUV-Based Assessment at 4 Cycles of Chemotherapy.
- Published in:
- Journal of Nuclear Medicine, 2009, v. 50, n. 4, p. 527, doi. 10.2967/jnumed.108.057703
- By:
- Publication type:
- Article
Analysis of a cohort of 279 patients with hairy-cell leukemia (HCL): 10 years of follow-up.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 5, p. 1, doi. 10.1038/s41408-020-0328-z
- By:
- Publication type:
- Article
Optimal oncologic management and mTOR inhibitor introduction are safe and improve survival in kidney and liver allograft recipients with de novo carcinoma.
- Published in:
- International Journal of Cancer, 2019, v. 144, n. 4, p. 886, doi. 10.1002/ijc.31769
- By:
- Publication type:
- Article
In Situ Hepatitis C NS3 Protein Detection Is Associated with High Grade Features in Hepatitis C-Associated B-Cell Non-Hodgkin Lymphomas.
- Published in:
- PLoS ONE, 2016, v. 11, n. 6, p. 1, doi. 10.1371/journal.pone.0156384
- By:
- Publication type:
- Article
First-line therapy for chronic lymphocytic leukemia in patients older than 79 years is feasible and achieves good results: A FILO retrospective study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Ibrutinib and idelalisib in the management of CLL‐associated autoimmune cytopenias: a study from the FILO group.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 7, p. E183, doi. 10.1002/ajh.25480
- By:
- Publication type:
- Article
Efficacy of chemotherapy or chemo‐anti‐PD‐1 combination after failed anti‐PD‐1 therapy for relapsed and refractory hodgkin lymphoma: A series from lysa centers.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 8, p. 1042, doi. 10.1002/ajh.25154
- By:
- Publication type:
- Article
Outcome of chronic lymphocytic leukemia patients who switched from either ibrutinib or idelalisib to alternate kinase inhibitor: A retrospective study of the French innovative leukemia organization (FILO).
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 2, p. E52, doi. 10.1002/ajh.24981
- By:
- Publication type:
- Article
Real-world results of ibrutinib in relapsed/refractory CLL in France: Early results on a large series of 428 patients.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 8, p. E166, doi. 10.1002/ajh.24773
- By:
- Publication type:
- Article
Ibrutinib in very elderly patients with relapsed/refractory chronic lymphocytic leukemia: A real-world experience of 71 patients treated in France: A study from the French Innovative Leukemia Organization (FILO) group.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 6, p. E105, doi. 10.1002/ajh.24715
- By:
- Publication type:
- Article
Efficacy and long-term toxicity of the rituximab-fludarabine-cyclophosphamide combination therapy in Waldenstrom's macroglobulinemia.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 8, p. 782, doi. 10.1002/ajh.24405
- By:
- Publication type:
- Article
Bendamustine and rituximab combination in the management of chronic lymphocytic leukemia-associated autoimmune hemolytic anemia: A multicentric retrospective study of the French CLL intergroup (GCFLLC/MW and GOELAMS).
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 3, p. 204, doi. 10.1002/ajh.23909
- By:
- Publication type:
- Article
Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B-cell non-Hodgkin lymphomas, ANRS HC-13 lympho-C study.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 3, p. 197, doi. 10.1002/ajh.23889
- By:
- Publication type:
- Article
Improved relapse-free survival after autologous stem cell transplantation does not translate into better quality of life in chronic lymphocytic leukemia: Lessons from the randomized European Society for Blood and Marrow Transplantation-Intergroup study.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 2, p. 174, doi. 10.1002/ajh.23610
- By:
- Publication type:
- Article
Evaluation of a new ELISA assay for monoclonal free‐light chain detection in patients with cardiac amyloidosis.
- Published in:
- EJHaem, 2022, v. 3, n. 3, p. 828, doi. 10.1002/jha2.516
- By:
- Publication type:
- Article
Early <sup>18</sup>F-FDG PET for Prediction of Prognosis in Patients with Diffuse Large B-Cell Lymphoma: SUV-Based Assessment Versus Visual Analysis.
- Published in:
- Journal of Nuclear Medicine, 2007, v. 48, n. 10, p. 1626, doi. 10.2967/jnumed.107.042093
- By:
- Publication type:
- Article